Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Front Endocrinol (Lausanne)

Center for Bone Quality, Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands.

Published: March 2022

[This corrects the article DOI: 10.3389/fendo.2021.782118.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964402PMC
http://dx.doi.org/10.3389/fendo.2022.877512DOI Listing

Publication Analysis

Top Keywords

corrigendum start
4
start bone-protecting
4
bone-protecting medication
4
medication preventing
4
preventing glucocorticoid-induced
4
glucocorticoid-induced osteoporosis
4
osteoporosis [this
4
[this corrects
4
corrects article
4
article doi
4

Similar Publications

Article Synopsis
  • The authors contacted the Editorial Office to clarify that their published article contained several errors, including incorrect mentions of specific circRNAs and their roles.
  • They highlighted specific lines that needed revisions, such as correcting errors regarding the regulation of the Wnt/β-catenin signaling pathway and the associated miRNAs involved.
  • Additionally, updates were necessary for Figure 3 and its legend to remove inaccurate references and correct the placement of visual elements; the authors expressed gratitude for the chance to publish their corrections and apologized for any confusion caused.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!